By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pharming Group N.V. 

P.O. Box 451

AL Leiden    2300  The Netherlands
Phone: 31-0-71-524-7400 Fax: +31-0-71-521-6507


Company News
Pharming Group (PHGUF.PK) Convene An Extraordinary General Meeting Of Shareholders 8/23/2016 8:55:44 AM
As Debt Repayments Loom, Valeant (VRX) Divests Ruconest Rights to Pharming Group (PHGUF.PK) for $125 Million 8/9/2016 5:42:31 AM
Pharming Group (PHGUF.PK) Reports On Financial Results For The First Six Months Of 2016 7/28/2016 10:46:53 AM
Pharming Group (PHGUF.PK) And CytoBioteck Announce Extension Of Distribution Agreement For Ruconest 2/9/2016 8:54:22 AM
Pharming Group (PHGUF.PK) Announces Completion Of Patient Enrolment In Clinical Study Of Ruconest For Prophylaxis Of Hereditary Angioedema 1/6/2016 9:25:57 AM
Pharming Group (PHGUF.PK) Release: European Medicines Agency Reaffirms Important Health Benefits And Safety Of Ruconest For Patients With Hereditairy Angioedema 12/7/2015 11:20:02 AM
Pharming Group (PHGUF.PK) Release: Interim Report January - September 2015 10/28/2015 11:48:34 AM
Pharming Group (PHGUF.PK) Nominates Mr Robin Wright As Chief Financial Officer 9/8/2015 10:38:44 AM
Pharming Group (PHGUF.PK) Reports On Financial Results First Half Year 2015 7/30/2015 9:08:24 AM
Pharming Group (PHGUF.PK) Release: HAEi Global Access Program for RUCONEST Now Live 7/21/2015 12:15:39 PM